HEPATITIS C
Clinical trials for HEPATITIS C explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C trials appear
Sign up with your email to follow new studies for HEPATITIS C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a helping hand from a peer cure hepatitis c after jail?
Disease control OngoingThis study aims to see if a peer support program helps people recently released from jail or prison get and stay in care for Hepatitis C. Researchers will compare this special program to standard care for 80 participants. The goal is to understand what helps or prevents people fr…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Apr 04, 2026 00:05 UTC
-
Doctors test giving hepatitis c kidneys to healthy patients
Disease control OngoingThis study tests whether kidneys from donors with hepatitis C can be safely transplanted into patients without hepatitis C who need a kidney transplant. After the transplant, recipients receive antiviral medication to prevent or treat hepatitis C infection. The goal is to expand …
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Amit D Tevar, MD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Doctors test using hepatitis C-Positive hearts to save lives on transplant waitlist
Disease control OngoingThis study is testing whether hearts from donors who have hepatitis C can be safely transplanted into patients who do not have the virus. The goal is to expand the pool of available donor hearts for people with severe heart failure. After transplant, patients receive antiviral me…
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Mary E. Keebler, MD • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for hepatitis c patients whose first treatment failed
Disease control ENROLLING_BY_INVITATIONThis study aims to find the best second treatment for people in Pakistan whose Hepatitis C infection did not clear after their first round of antiviral drugs. It will compare two different lengths of a follow-up drug combination (12 weeks vs. 24 weeks) in about 318 adults. The go…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Phone-Based care aims to curb HIV and cure hepatitis c in High-Risk group
Disease control OngoingThis study is testing two different telemedicine methods to quickly start people who inject drugs on medications for HIV, Hepatitis C, and opioid addiction. It aims to see which approach is better at getting HIV under control, curing Hepatitis C, and helping people start addictio…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Drug combo shields transplant patients from donor hepatitis c
Prevention OngoingThis study tests whether a short course of two drugs can prevent hepatitis C from spreading when an organ from an infected donor is transplanted into an uninfected patient. It involves 200 kidney, heart, lung, or pancreas transplant recipients who agree to accept an organ from a …
Matched conditions: HEPATITIS C
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Apr 02, 2026 14:56 UTC